Lv7
4680 积分 2023-11-20 加入
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial
26天前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
27天前
已完结
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
28天前
已完结
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation
1个月前
已完结
The value of preoperative radiotherapy in the treatment of locally advanced nasal cavity and paranasal sinus squamous cell carcinoma: A single institutional experience
1个月前
已完结
Comparative Study of Hypofractionated vs. Conventional Chemoradiation in Locally Advanced Head and Neck Cancer
1个月前
已完结
Targeting the PD1/PD-L1 axis in melanoma: biological rationale, clinical challenges and opportunities
1个月前
已完结
Total Neoadjuvant Therapy for Pancreatic Cancer-What Is Totality?
1个月前
已完结
Neoadjuvant Treatment Is Associated With Superior Outcomes in T4 Lung Cancers With Local Extension
1个月前
已完结
Neoadjuvant chemoimmunotherapy for locally advanced squamous cell carcinoma of the head and neck: Systematic review and meta-analysis
2个月前
已完结
皖公网安备34019202002308
